What is Giotrif 40 mg, film-coated tablets used for?

( ARTG ) GIOTRIF is indicated as monotherapy for the treatment of adult patients with:, Locally advanced or metastatic non-squamous non-small cell carcinoma of the lung, either as first line therapy or after failure of cytotoxic chemotherapy. Tumours must have activating Epidermal Growth Factor Receptor (EGFR) mutations., Locally advanced or metastatic squamous non-small cell carcinoma of the lung progressing on or after platinum-based chemotherapy.

What are the side effects of Giotrif 40 mg, film-coated tablets?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Giotrif 40 mg, film-coated tablets be used during pregnancy?

( AHT ) For the active ingredient afatinib You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures Giotrif 40 mg, film-coated tablets?

Boehringer Ingelheim (Schweiz) GmbH (CH)

What ATC class does Giotrif 40 mg, film-coated tablets belong to?

Giotrif 40 mg, film-coated tablets: ATC L01EB03. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Giotrif 40 mg, film-coated tablets

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Boehringer Ingelheim (Schweiz) GmbH

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.